### 2854 Federal Register / Vol. 79, No. 11 / Thursday, January 16, 2014 / Notices

the current ONC–AA (ANSI). Accordingly, this notice is issued pursuant to § 170.503(b), which requires the National Coordinator for Health Information Technology (the National Coordinator) to publish a notice in the Federal Register to announce the 30-day period during which requests for ONC– AA status may be submitted. In order to be considered for ONC–AA status, an accreditation organization must submit a written request to the National Coordinator that includes the information required by § 170.503(b) within the 30-day period specified in this notice. Section 170.503(b) requires an accreditation organization to submit the following information to demonstrate its ability to serve as an
ONC–AA:

(1) A detailed description of the accreditation organization’s conformance to ISO/IEC17011:2004 (incorporated by reference in § 170.599) and experience evaluating the conformance of certification bodies to ISO/IEC Guide 65:1996 (incorporated by reference in § 170.599);

(2) A detailed description of the accreditation organization’s accreditation requirements[,] as well as how those requirements would complement the Principles of Proper Conduct for ONC–ACBs and ensure the surveillance approaches used by ONC– ACBs include the use of consistent, objective, valid, and reliable methods;

(3) Detailed information on the accreditation organization’s procedures that would be used to monitor ONC– ACBs;

(4) Detailed information, including education and experience, about the key personnel who review organizations for accreditation; and

(5) Procedures for responding to, and investigating, complaints against ONC–
ACBs.

Requests for ONC–AA status may be submitted by email to ONC–AA@ hhs.gov and should include ‘‘Request for ONC–AA Status’’ in the subject line. Alternatively, requests for ONC–AA status may be submitted by regular or express mail to: Office of the National Coordinator for Health Information Technology, Attention: ONC HIT Certification Program—Request for ONC–AA Status, 330 C Street SW., Washington, DC 20201. In accordance with § 170.505, the official date of receipt of an email submission will be the date on which it was sent, and the official date of a submission by regular or express mail will be the date of the delivery confirmation. To clarify, email submissions may be sent up to and through 11:59 p.m. on the last day of the submission period. Additional information about requesting ONC–AA status and the ONC HIT Certification Program can be found on the ONC Web
site at: http://healthit.hhs.gov/ certification.

Dated: January 10, 2014. Jacob Reider, Acting National Coordinator for Health Information Technology.

[FR Doc. 2014–00797 Filed 1–15–14; 8:45 am]

**BILLING CODE 4150–45–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention** 

**[Docket Number CDC–2014–0002; NIOSH 248–A]** 

**World Trade Center Health Program Scientific/Technical Advisory**  **Committee (WTCHP STAC or Advisory Committee), National Institute for**  **Occupational Safety and Health (NIOSH)** 

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee:

Time and Date: 9:30 a.m.–5:00 p.m., February 14, 2014 (All times are Eastern Standard Time)

Place: This meeting will be available via telephone and Web Conference. Audio will be available by telephone and visuals will be available by Web Conference. The USA toll-free, dial-in number is 1 (888) 381–5771. To be connected to the meeting, you will need to provide the following participant code to the operator: 8501294. To obtain further instructions on how to access the meeting online through Web Conference, see the instructions at the Committee’s meeting Web site: http:// www.cdc.gov/wtc/stac

_meeting.html

. Public Comment Time and Date: 11:30 a.m.–12:15 p.m., February 14,

2014.

Please note that the public comment period ends at the time indicated above or following the last call for comments, whichever is earlier. Members of the public who want to comment must sign up by providing their name by mail, email, or telephone, at the addresses provided below, by February 10, 2014. Each commenter will be provided up to five minutes for comment. A limited number of time slots are available and will be assigned on a first come-first served basis. Written comments will also be accepted from those unable to attend the public session. Status: Open to the public, limited only by the number of telephone lines. The conference line will accommodate up to 100 callers; therefore it is suggested that those interested in calling in to listen to the committee meeting share a line when possible.

Background: The Advisory Committee was established by Public Law 111–347 (The James Zadroga 9/11 Health and Compensation Act of 2010, Title XXXIII of the Public Health Service Act), enacted on January 2, 2011 and codified
at 42 U.S.C. sec. 300mm–300mm–61.

Purpose: The purpose of the Advisory Committee is to review scientific and medical evidence and to make recommendations to the World Trade Center (WTC) Program Administrator regarding additional WTC Health Program eligibility criteria and potentialadditions to the list of covered WTCrelated health conditions. Title XXXIII of the Public Health Service Act established within the Department of Health and Human Services (HHS), the World Trade Center (WTC) Health Program, to be administered by the WTC Program Administrator. The WTC Health Program provides: (1) Medical monitoring and treatment benefits to eligible emergency responders and recovery and cleanup workers (including those who are Federal employees) who responded to the September 11, 2001, terrorist attacks, and (2) initial health evaluation, monitoring, and treatment benefits to residents and other building occupants and area workers in New York City, who were directly impacted and adversely affected by such attacks (‘‘survivors’’). Certain specific activities of the WTC Program Administrator are reserved to the Secretary, HHS, to delegate at her discretion; other WTC Program Administrator duties not explicitly reserved to the Secretary, HHS, are assigned to the Director, NIOSH. The administration of the Advisory Committee established under Section 300mm–1(a) is left to the Director of NIOSH in his role as WTC Program Administrator. CDC and NIOSH provide funding, staffing, and administrative support services for the Advisory Committee. The charter was reissued on May 9, 2013, and will expire on May 9,

2015.

Matters To Be Discussed: The agenda for the Advisory Committee meeting includes a brief update on the policies and regulations developed by the WTC Health Program and development of recommendations for research.

The agenda is subject to change as priorities dictate.

To view the notice, visit http:// www.regulations.gov and enter CDC–


### 2855 Federal Register / Vol. 79, No. 11 / Thursday, January 16, 2014 / Notices

2014–0002 in the search field and click ‘‘Search.’’

Public Comment Sign-up and Submissions to the Docket: To sign up to provide public comments or to submit comments to the docket, send information to the NIOSH Docket Office by one of the following means:

Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS–C–34, 4676 Columbia Parkway, Cincinnati, Ohio

45226.

Email: nioshdocket@cdc.gov. Telephone: (513) 533–8611. In the event an individual cannot attend, written comments may be submitted. The comments should be limited to two pages and submitted through http://www.regulations.gov by February 10, 2014. Efforts will be made to provide the two-page written comments received by the deadline below to the committee members before the meeting. Comments in excess of two pages will be made publicly available at http://www.regulations.gov. To view background information and previous submissions go to NIOSH docket http:// www.cdc.gov/niosh/docket/archive/ docket248.html

.

Policy on Redaction of Committee Meeting Transcripts (Public Comment): Transcripts will be prepared and posted

to http://www.regulations.gov within 60 days after the meeting. If a person making a comment gives his or her name, no attempt will be made to redact that name. NIOSH will take reasonable steps to ensure that individuals making public comments are aware of the fact that their comments (including their name, if provided) will appear in a transcript of the meeting posted on a public Web site. Such reasonable steps include a statement read at the start of the meeting stating that transcripts will be posted and names of speakers will not be redacted. If individuals in making a statement reveal personal information (e.g., medical information) about themselves, that information will not usually be redacted. The CDC Freedom of Information Act coordinator will, however, review such revelations in accordance with the Freedom of Information Act and, if deemed appropriate, will redact such information. Disclosures of information concerning third party medical information will be redacted.

Contact Person For More Information: Paul J. Middendorf, Ph.D., Designated Federal Officer, NIOSH, CDC, 2400 Century Parkway NE., Mail Stop E–20, Atlanta, Georgia 30345, telephone 1 (888) 982–4748; email: wtc-stac@ cdc.gov.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and
Prevention.

[FR Doc. 2014–00715 Filed 1–15–14; 8:45 am]

**BILLING CODE 4163–18–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention** 

**Disease, Disability, and Injury Prevention and Control Special**  **Emphasis Panel (SEP): Initial Review**

The meeting announced below concerns Occupational Safety and Health Education and Research Centers (ERC) PAR 10–217, initial review.

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times and Dates: 6:00 p.m.–7:00 p.m., February 24, 2014 (Closed) 8:00 a.m.–5:00 p.m., February 25, 2014 (Closed) 8:00 a.m.–5:00 p.m., February 26, 2014 (Closed) 8:00 a.m.–12:00 p.m., February 27, 2014 (Closed) Place: Courtyard Marriott, 130 Clairemont Drive, Decatur, Georgia 30030, Telephone: (404) 371–0204.

Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–

463.

Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Occupational Safety and Health Education and Research Centers (ERC)
PAR 10–217’’.

Contact Person For More Information: George Bockosh, M.S., Scientific Review Officer, CDC/NIOSH, 626 Cochrans Mill Road, Mailstop P–05, Pittsburgh, Pennsylvania 15236, Telephone: (412) 386–6465 and Joan F. Karr, Ph.D., Scientific Review Officer, CDC/NIOSH 1600 Clifton Road NE., Mailstop E–74, Atlanta, Georgia 30333, Telephone: (404) 498–2506.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and
Prevention.

[FR Doc. 2014–00714 Filed 1–15–14; 8:45 am]

**BILLING CODE 4163–18–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention (CDC)** 

**Request for Nominations of Candidates To Serve on the Advisory**  **Committee on Breast Cancer in Young**
**Women**

The Centers for Disease Control and Prevention (CDC) is soliciting nominations for possible membership on the Advisory Committee on Breast Cancer in Young Women (ACBCYW).

The Committee provides advice and guidance to the Secretary, HHS; the Assistant Secretary for Health; and the Director, CDC, regarding the formative research, development, implementation and evaluation of evidence-based activities designed to prevent breast cancer (particularly among those at heightened risk) and promote the early detection and support of young women who develop the disease. The advice provided by the Committee will assist in ensuring scientific quality, timeliness, utility, and dissemination of credible appropriate messages and resource materials.

Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of the committee’s objectives.

The Secretary, HHS, acting through the Director, CDC, shall appoint to the advisory committee nominees with expertise in breast cancer, disease prevention, early detection, diagnosis, public health, social marketing, genetic screening and counseling, treatment, rehabilitation, palliative care, and survivorship in young women, or in related disciplines with a specific focus on young women. Members may be invited to serve for up to four years. The next cycle of selection of candidates